Search

everythinglearnresearchcommunity

for

Search:↓

The 0.25% finasteride solution, when applied once a day, effectively reduces scalp DHT, potentially minimizing sexual side-effects linked to a systemic DHT reduction.

Nanoparticle-based drug delivery to hair follicles is more effective when tested under conditions that match skin behavior.

A new method using hydrogels and microneedle patches improves minoxidil delivery for better hair growth.

A new method using stem cell membranes to deliver Minoxidil improved hair growth in mice better than Minoxidil alone.

Microneedling can improve hair growth in people not responding to standard treatments.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Low-dose oral minoxidil can help increase hair growth in women with hair loss.

Both new minoxidil formulations significantly stimulated hair growth and improved dermal metabolism.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Nanoparticle-embedded microneedles improve drug delivery through the skin but face challenges in stability and safety.

Low-dose oral minoxidil effectively promotes hair growth with minimal side effects.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

Tanshinone compounds can help prevent hair loss caused by testosterone.

Dutasteride-loaded nanoparticles coated with Lauric Acid-Chitosan show promise for treating hair loss due to their controlled release, low toxicity, and potential to stimulate hair growth.

Media attention increased oral minoxidil prescriptions for English-preferring patients but not for Spanish-preferring patients.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

The method effectively measures drug impact on DHT levels in prostate treatments.

Oral minoxidil has more side effects but can be more effective than topical minoxidil.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

A new treatment using microneedles with black phosphorus and laser helps regrow hair effectively and safely.

Locally made finasteride tablets work the same as imported ones.

The new gel improves skin delivery of a drug, potentially reducing dose frequency and side effects.

A new method was developed to analyze certain hormones and drugs in human blood efficiently.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

400 nm particles penetrate hair follicles best, but mouse models aren't fully reliable for human studies.